Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
Artificial intelligence agents powered by the world's most advanced language models routinely fail to complete even straightforward professional tasks on their own, according to groundbreaking re [...]
Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligen [...]
Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]
2025 was supposed to be the year of "AI agents," according to Nvidia CEO Jensen Huang, and other AI industry personnel. And it has been, in many ways, with numerous leading AI model provider [...]
Anthropic today launched two new AI models — Claude Fable 5 and Claude Mythos 5 — marking the company’s first broad release of the powerful “Mythos-class” AI capabilities it previously kept [...]
Isomorphic Labs, the AI drug research company led by DeepMind co-founder Demis Hassabis, has closed a $2.1 billion Series B round led by Thrive Capital. The funding will go toward expanding its in-hou [...]